Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) has announced its schedule for the second quarter 2024 earnings conference call, set for August 8, 2024, at 10:00 AM ET. The company will release its financial results for the quarter ended June 30, 2024, before the market opens on the same day. Interested participants can register for the call to ask questions, while an audio-only webcast option is also available. Financial information, including the earnings release and a related slide presentation, will be accessible on the Investor Relations section of Harvard Bioscience's website.

HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8, 2024, and will hold a conference call to discuss the results at 10:00 a.m. Eastern Time. 

Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.

Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120

Investors Contact:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207

FAQ

When is Harvard Bioscience (HBIO) releasing its Q2 2024 earnings?

Harvard Bioscience (HBIO) will release its Q2 2024 earnings before the market opens on August 8, 2024.

What time is Harvard Bioscience's (HBIO) Q2 2024 earnings conference call?

Harvard Bioscience's (HBIO) Q2 2024 earnings conference call is scheduled for August 8, 2024, at 10:00 AM Eastern Time.

How can I participate in Harvard Bioscience's (HBIO) Q2 2024 earnings call?

To participate and ask questions in Harvard Bioscience's (HBIO) Q2 2024 earnings call, you need to register through the provided link. An audio-only webcast option is also available on the company's investor website.

Where can I find Harvard Bioscience's (HBIO) Q2 2024 financial information and earnings release?

Harvard Bioscience's (HBIO) Q2 2024 financial information, earnings release, and related slide presentation will be available on the Investor Relations section of the company's website.